Federica Longo

Dr. Federica Longo


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2025 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
KIKomal Imran
Komal Imran
MIMuhammad Javed Iqbal
Muhammad Javed Iqbal
MAMuhammad Mushtaq Ahmad
Muhammad Mushtaq Ahmad
AKAmmara Khalid
Ammara Khalid
Hernán CortésHernán Cortés
Hernán Cortés
Daniela CalinaDaniela Calina
Daniela Calina

Verified
Journal Article
Open access
PDF file
Claudia LombardoClaudia Lombardo
Claudia Lombardo
RFRosanna Fazio
Rosanna Fazio
MSMarta Sinagra
Marta Sinagra
Giuseppe GattusoGiuseppe Gattuso
Giuseppe Gattuso
FLFederica Longo
Federica Longo
Carla LoretoCarla Loreto
Carla Loreto
The human microbiota represents a heterogeneous microbial community composed of several commensal, symbiotic, and even pathogenic microorganisms colonizing both the external and internal body surfaces. Despite the term “microbiota” being commonly used to identify microorganisms inhabiting the gut, several pieces of evidence suggest the presence of different microbiota physiologically colonizing other organs. In this context, several studies have also confirmed that microbes are integral components of tumor tissue in different types of cancer, constituting the so-called “intratumoral microbiota”. The intratumoral microbiota is closely related to the occurrence and development of cancer as well as to the efficacy of anticancer treatments. Indeed, intratumoral microbiota can contribute to carcinogenesis and metastasis formation as some microbes can directly cause DNA damage, while others can induce the activation of proinflammatory responses or oncogenic pathways and alter the tumor microenvironment (TME). All these characteristics make the intratumoral microbiota an interesting topic to investigate for both diagnostic and prognostic purposes in order to improve the management of cancer patients. This review aims to gather the most recent data on the role of the intratumoral microbiota in cancer development, progression, and response to treatment, as well as its potential diagnostic and prognostic value.

Verified
Journal Article
Open access
PDF file
Giuseppe GattusoGiuseppe Gattuso
Giuseppe Gattuso
FLFederica Longo
Federica Longo
GSGraziana Spoto
Graziana Spoto
DRDaria Ricci
Daria Ricci
Alessandro LavoroAlessandro Lavoro
Alessandro Lavoro
Luca FalzoneLuca Falzone
Luca Falzone
Colorectal cancer (CRC) is the fourth most commonly diagnosed cancer and one of the leading causes of cancer death worldwide. Despite diagnostic and therapeutic advances, CRC mortality remains high, especially in industrialized countries. Numerous studies have highlighted the pathogenetic role of altered microRNA (miRNA) expression among the various factors contributing to the development and progression of colorectal cancer (CRC). However, the data regarding specific miRNAs involved in CRC pathogenesis remain inconsistent, and no miRNAs have been recognized so far as reliable or effective biomarkers for the diagnosis of this tumor type. To identify novel miRNA biomarkers in CRC, this study validated the expression levels of a four-miRNA signature predicted to be involved in CRC by analyzing both tissue and liquid biopsy samples. Our experimental and bioinformatics results highlighted the diagnostic potential of hsa-miR-21-5p, hsa-miR-503-5p, and hsa-miR-375, as well as the potential prognostic value of hsa-miR-497-5p overexpression and hsa-miR-375-3p downregulation. Overall, the results obtained suggest the diagnostic and prognostic significance of this four-miRNA signature in CRC.